Contact

All Stories

  1. Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study

    Article • Diabetologia, November 2025, Springer Science + Business Media

    Dr Viral N Shah

  2. iCoDE-2 September 18, 2025 Steering Committee Final Meeting Summary Report

    Article • Journal of Diabetes Science and Technology, October 2025, SAGE Publications

    Dr Viral N Shah

  3. Hypophosphatasia and Type 1 Diabetes: A Pilot Study and Review of Literature

    Article • Current Osteoporosis Reports, October 2025, Springer Science + Business Media

    Dr Viral N Shah

  4. Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence From Real-World Type 1 Diabetes Care

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2025, Endocrine Society

    Dr Viral N Shah

  5. Recombinant Human GH in Managing Refractory Hypoglycemia in a Young Patient With Embryonal Rhabdomyosarcoma

    Article • JCEM Case Reports, July 2025, Endocrine Society

    Dr Viral N Shah

  6. Association Between Time-in-Range and Diabetic Retinopathy: Learnings from DCCT to Recent Times

    Article • Diabetes Technology & Therapeutics, May 2025, Mary Ann Liebert Inc

    Dr Viral N Shah

  7. Navigating Automated Insulin Delivery for Type 1 Diabetes Management During Pregnancy

    Article • Journal of Diabetes Science and Technology, April 2025, SAGE Publications

    Dr Viral N Shah

  8. Changes in A1C Versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2025, Endocrine Society

    Dr Viral N Shah

  9. Quantifying Environmental Waste From Diabetes Devices in the U.S.

    Article • Diabetes Care, March 2025, American Diabetes Association

    Dr Viral N Shah

  10. Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control

    Article • Diabetes Technology & Therapeutics, March 2025, Mary Ann Liebert Inc

    Dr Viral N Shah

  11. Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin‐naive adults with suboptimally controlled type 2 diabetes

    Article • Diabetes Obesity and Metabolism, February 2025, Wiley

    Dr Viral N Shah

  12. Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes

    Article • Journal of Diabetes Science and Technology, February 2025, SAGE Publications

    Dr Viral N Shah

  13. Prescribed Total Daily Insulin Dose and Predictors of Insulin Dose for Adults with Type 2 Diabetes on Multiple Daily Injections of Insulin: A Retrospective Cohort Study

    Article • Diabetology, February 2025, MDPI AG

    Dr Viral N Shah

  14. Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies

    Article • Journal of Diabetes Science and Technology, December 2024, SAGE Publications

    Dr Viral N Shah

  15. Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System

    Article • Journal of Diabetes Science and Technology, November 2024, SAGE Publications

    Dr Viral N Shah

  16. Prediction of Incident Diabetic Retinopathy in Adults With Type 1 Diabetes Using Machine Learning Approach: An Exploratory Study

    Article • Journal of Diabetes Science and Technology, October 2024, SAGE Publications

    Dr Viral N Shah

  17. Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes

    Article • Clinical Diabetes, September 2024, American Diabetes Association

    Dr Viral N Shah

  18. Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report

    Article • Endocrine Practice, September 2024, Elsevier

    Dr Viral N Shah

  19. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting

    Article • Diabetes Research and Clinical Practice, June 2024, Elsevier

    Dr Viral N Shah

  20. The Association of High and Low Glycation With Incident Diabetic Retinopathy in Adults With Type 1 Diabetes

    Article • Journal of Diabetes Science and Technology, May 2024, SAGE Publications

    Dr Viral N Shah

  21. Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ

    Article • Diabetes Therapy, May 2024, Springer Science + Business Media

    Dr Viral N Shah

  22. Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity

    Article • Journal of Diabetes Science and Technology, April 2024, SAGE Publications

    Dr Viral N Shah

  23. Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?

    Article • Journal of Diabetes Science and Technology, April 2024, SAGE Publications

    Dr Viral N Shah

  24. Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study

    Article • Diabetes Technology & Therapeutics, April 2024, Mary Ann Liebert Inc

    Dr Viral N Shah

  25. Maternal diabetes and fracture risk in offspring: a population-based analysis

    Article • Journal of Bone and Mineral Research, March 2024, Oxford University Press (OUP)

    Dr Viral N Shah

  26. Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial

    Article • Journal of Diabetes Science and Technology, March 2024, SAGE Publications

    Dr Viral N Shah

  27. Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial

    Article • Journal of Diabetes Science and Technology, February 2024, SAGE Publications

    Dr Viral N Shah

  28. Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology

    Article • Journal of Diabetes Science and Technology, February 2024, SAGE Publications

    Dr Viral N Shah

  29. Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study

    Article • Journal of Diabetes Science and Technology, February 2024, SAGE Publications

    Dr Viral N Shah

  30. Limitations of Reporting Time Below Range as a Percentage

    Article • Diabetes Technology & Therapeutics, November 2023, Mary Ann Liebert Inc

    Dr Viral N Shah

  31. Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of

    Article • Diabetes Obesity and Metabolism, October 2023, Wiley

    Dr Viral N Shah

  32. Bone Structure and Turnover in Postmenopausal Women With Long‐Standing Type 1 Diabetes

    Article • JBMR Plus, October 2023, Oxford University Press (OUP)

    Dr Viral N Shah

  33. Skeletal Health in Patients With Mitochondrial Diabetes: Case Series and Review of Literature

    Article • JBMR Plus, September 2023, Oxford University Press (OUP)

    Dr Viral N Shah

  34. Minimum Sampling Duration for Continuous Glucose Monitoring Metrics to Achieve Representative Glycemic Outcomes in Suboptimal Continuous Glucose Monitor Use

    Article • Journal of Diabetes Science and Technology, September 2023, SAGE Publications

    Dr Viral N Shah

  35. Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade

    Article • Diabetes Care, July 2023, American Diabetes Association

    Dr Viral N Shah

  36. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes

    Article • Diabetes Obesity and Metabolism, July 2023, Wiley

    Dr Viral N Shah

  37. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes

    Article • Diabetes Technology & Therapeutics, May 2023, Mary Ann Liebert Inc

    Dr Viral N Shah

  38. Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index

    Article • Diabetes Technology & Therapeutics, February 2023, Mary Ann Liebert Inc

    Dr Viral N Shah

  39. Higher Prevalence of Hypoglycemia and Unsafe Driving Practices in Adults With Type 1 Diabetes

    Article • Diabetes Care, January 2023, American Diabetes Association

    Dr Viral N Shah

  40. Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes

    Article • Diabetes Technology & Therapeutics, January 2023, Mary Ann Liebert Inc

    Dr Viral N Shah

  41. Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes

    Article • Diabetes Technology & Therapeutics, October 2022, Mary Ann Liebert Inc

    Dr Viral N Shah

  42. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration

    Article • Diabetes Technology & Therapeutics, October 2022, Mary Ann Liebert Inc

    Dr Viral N Shah

  43. Retained Diabetes Devices—A Literature Review

    Article • Journal of Diabetes Science and Technology, July 2022, SAGE Publications

    Dr Viral N Shah

  44. Health Care Professionals’ Perspectives on Use of Diabetes Technologies for Managing Visually Impaired Patients With Diabetes

    Article • Journal of Diabetes Science and Technology, June 2022, SAGE Publications

    Dr Viral N Shah

  45. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled trials

    Article • Diabetic Medicine, April 2022, Wiley

    Dr Viral N Shah

  46. Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study

    Article • Diabetes Care, January 2022, American Diabetes Association

    Dr Viral N Shah

  47. Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

    Article • Diabetes Care, December 2021, American Diabetes Association

    Dr Viral N Shah

  48. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes

    Article • Diabetes Technology & Therapeutics, December 2021, Mary Ann Liebert Inc

    Dr Viral N Shah

  49. Off‐label use of sodium glucose co‐transporter inhibitors among adults in type 1 diabetes exchange registry

    Article • Diabetes Obesity and Metabolism, October 2021, Wiley

    Dr Viral N Shah

  50. A randomized controlled trial of transition from insulin pump to multiple daily injections using insulin degludec

    Article • Diabetes Obesity and Metabolism, June 2021, Wiley

    Dr Viral N Shah

  51. Health-related quality of life in parents and partners of people with type 1 diabetes: Development and validation of type 1 diabetes and life (T1DAL) measures.

    Article • Families Systems & Health, June 2021, American Psychological Association (APA)

    Marisa Hilliard, Barbara Anderson, Dr Viral N Shah

  52. Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards

    Article • Diabetes Care, May 2021, American Diabetes Association

    Dr Viral N Shah

  53. Acute Hyperinsulinemia Alters Bone Turnover in Women and Men With Type 1 Diabetes

    Article • JBMR Plus, August 2020, Oxford University Press (OUP)

    Dr Viral N Shah

  54. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network ( United States ) and the prospective diabetes follow‐up (Germany/Austria) registries

    Article • Diabetes Obesity and Metabolism, May 2020, Wiley

    Dr Viral N Shah

  55. Suicide via Intentional Insulin Overdose Through First Commercial Hybrid Closed-Loop

    Article • Journal of Diabetes Science and Technology, March 2020, SAGE Publications

    Dr Viral N Shah

  56. Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1)

    Article • Diabetes Technology & Therapeutics, February 2020, Mary Ann Liebert Inc

    Dr Viral N Shah

  57. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2020, Endocrine Society

    Dr Viral N Shah

  58. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes

    Article • Diabetes Care, January 2020, American Diabetes Association

    Dr Viral N Shah

  59. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2019, Endocrine Society

    Dr Viral N Shah

  60. Cannabis Use Is Associated With Increased Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes: Findings From the T1D Exchange Clinic Registry

    Article • Diabetes Care, October 2019, American Diabetes Association

    Dr Viral N Shah

  61. Letter to editor in response to article published by Leanza et al.

    Article • Bone, October 2019, Elsevier

    Dr Viral N Shah

  62. Type 1 diabetes onset at young age is associated with compromised bone quality

    Article • Bone, June 2019, Elsevier

    Dr Viral N Shah

  63. Association Between Cannabis Use and Risk for Diabetic Ketoacidosis in Adults With Type 1 Diabetes

    Article • JAMA Internal Medicine, January 2019, American Medical Association (AMA)

    Dr Viral N Shah

  64. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes

    Article • Diabetes Technology & Therapeutics, January 2019, Mary Ann Liebert Inc

    Dr Viral N Shah

  65. Determinants of fracture in adults with type 1 diabetes in the USA: Results from the T1D Exchange Clinic Registry

    Article • Journal of Diabetes and its Complications, November 2018, Elsevier

    Michael Rickels Rickels, Dr Viral N Shah

  66. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

    Article • The Lancet, October 2018, Elsevier

    Dr Viral N Shah

  67. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry

    Article • Journal of Diabetes and its Complications, October 2018, Elsevier

    Dr Viral N Shah

  68. Bone health in type 1 diabetes

    Article • Current Opinion in Endocrinology Diabetes and Obesity, August 2018, Wolters Kluwer Health

    Dr Viral N Shah

  69. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange

    Article • Diabetes Technology & Therapeutics, August 2018, Mary Ann Liebert Inc

    Dr Viral N Shah

  70. Bone and Vascular Health in Postmenopausal Women with Type 1 Diabetes

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Viral N Shah

  71. Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes (T1D)—Findings from the T1D Exchange

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Viral N Shah

  72. Coronary Artery Calcium Trajectory Predicts Coronary Artery Disease Events—The CACTI Study

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Viral N Shah

  73. Increased HbA1c Variability May Shorten Time to Microalbuminuria Development in Type 1 Diabetes (T1D)

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Viral N Shah

  74. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes (T1D)

    Article • Diabetes, July 2018, American Diabetes Association

    Dr Viral N Shah

  75. Severe hypoglycemia is associated with high risk for falls in adults with type 1 diabetes

    Article • Archives of Osteoporosis, June 2018, Springer Science + Business Media

    Dr Viral N Shah

  76. Bone mineral content and bone density is lower in adolescents with type 1 diabetes : A brief report from the RESISTANT and EMERALD studies

    Article • Journal of Diabetes and its Complications, June 2018, Elsevier

    Dr Viral N Shah

  77. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes

    Article • Diabetes Technology & Therapeutics, June 2018, Mary Ann Liebert Inc

    Dr Viral N Shah

  78. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator

    Article • Diabetes Technology & Therapeutics, June 2018, Mary Ann Liebert Inc

    Dr Viral N Shah

  79. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes

    Article • Journal of Clinical Investigation, April 2018, American Society for Clinical Investigation

    Dr Viral N Shah

  80. Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes

    Article • Diabetes Obesity and Metabolism, March 2018, Wiley

    Dr Viral N Shah

  81. Complications With Insulin Pump Therapy vs Insulin Injection Therapy

    Article • JAMA, February 2018, American Medical Association (AMA)

    Dr Viral N Shah

  82. Olmesartan in Management of Proteinuria

    Article • JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, January 2018, JCDR Research and Publications

    Dr Viral N Shah

  83. Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance

    Article • Osteoporosis International, December 2017, Springer Science + Business Media

    Dr Viral N Shah

  84. Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry

    Article • Journal of Diabetes and its Complications, December 2017, Elsevier

    Dr Viral N Shah

  85. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel stud...

    Article • BMJ Open, July 2017, BMJ

    Dr Viral N Shah

  86. Glycemic Control With Early Initiation of Continuous Glucose Monitoring System in Adults With Recently Diagnosed Type 1A Diabetes

    Article • Journal of Diabetes Science and Technology, June 2017, SAGE Publications

    Dr Viral N Shah

  87. Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults with Type 1 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2017, Endocrine Society

    Dr Viral N Shah, Dr Morey W. Haymond, Michael Rickels Rickels

  88. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature

    Article • Osteoporosis International, June 2017, Springer Science + Business Media

    Dr Viral N Shah

  89. Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management

    Article • Diabetes Therapy, May 2017, Springer Science + Business Media

    Dr Viral N Shah

  90. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

    Article • Diabetes Care, February 2017, American Diabetes Association

    Michael Rickels Rickels, Dr Viral N Shah

  91. A novel option for prandial insulin therapy: inhaled insulin

    Article • Postgraduate Medicine, September 2016, Taylor & Francis

    Dr Viral N Shah

  92. An Unusual Cause of Recurrent Diabetic Ketoacidosis in Type 1 Diabetes

    Article • The American Journal of Medicine, August 2016, Elsevier

    Dr Viral N Shah

  93. Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies

    Article • Current Pharmaceutical Design, May 2016, Bentham Science Publishers

    Dr Viral N Shah

  94. Pulmonary Function Tests in Sickle Cell Disease

    Article • The Indian Journal of Pediatrics, March 2016, Springer Science + Business Media

    Dr Viral N Shah

  95. Insulin delivery methods: Past, present and future

    Article • International Journal of Pharmaceutical Investigation, January 2016, Medknow

    Dr Viral N Shah

  96. Psychological Aspects Related to Diabetes Mellitus

    Article • Journal of Diabetes Research, January 2016, Wiley

    Dr Viral N Shah

  97. Pustulovesicular skin eruption as presenting feature of incomplete kawasaki disease

    Article • Annals of Medical and Health Sciences Research, January 2016, Medknow

    Dr Viral N Shah

  98. Managing diabetes in the digital age

    Article • Clinical Diabetes and Endocrinology, December 2015, Springer Science + Business Media

    Dr Viral N Shah

  99. Comment on Weber et al. Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN). Diabetes Care 2015;38:1913–1920

    Article • Diabetes Care, November 2015, American Diabetes Association

    Dr Viral N Shah

  100. Risk factors for proteinuria and renal insufficiency in Asian Indian patients with type 2 diabetes

    Article • International Journal of Diabetes in Developing Countries, August 2015, Springer Science + Business Media

    Dr Viral N Shah

  101. Diabetes in India

    Article • Current Opinion in Endocrinology Diabetes and Obesity, August 2015, Wolters Kluwer Health

    Dr Viral N Shah

  102. Type 1 diabetes and risk of fracture: meta‐analysis and review of the literature

    Article • Diabetic Medicine, June 2015, Wiley

    Dr Viral N Shah

  103. Association Between Bone Mineral Density and type 1 Diabetes Mellitus: A meta-Analysis of Observational Studies

    Article • Value in Health, May 2015, Elsevier

    Dr Viral N Shah

  104. Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience

    Article • Endocrine Connections, March 2015, Bioscientifica

    Dr Viral N Shah

  105. Comment on Liu et al. Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes: A Nationwide, Multicenter Prospective Study (LADA China Study 3). Diabetes Care 2015;38:16–21

    Article • Diabetes Care, February 2015, American Diabetes Association

    Dr Viral N Shah

  106. New Medications for the Treatment of Diabetes

    Article • Diabetes Technology & Therapeutics, February 2015, Mary Ann Liebert Inc

    Dr Viral N Shah

  107. Closed-Loop System in the Management of Diabetes: Past, Present, and Future

    Article • Diabetes Technology & Therapeutics, August 2014, Mary Ann Liebert Inc

    Dr Viral N Shah

  108. Effect of Vitamin D Replacement on Hemoglobin Concentration in Subjects with Concurrent Iron-Deficiency Anemia and Vitamin D Deficiency: A Randomized, Single-Blinded, Placebo-Controlled Trial

    Article • Acta Haematologica, July 2014, Karger Publishers

    Dr Viral N Shah, Prof NARESH SACHDEVA

  109. Newer Therapies for Diabetes Management

    Article • Diabetes Technology & Therapeutics, February 2014, Mary Ann Liebert Inc

    Dr Viral N Shah

  110. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta‐analysis and re...

    Article • Clinical Endocrinology, January 2014, Wiley

    Dr Viral N Shah

  111. Choice of fluid therapy in patients of craniopharyngioma in the perioperative period: A hospital-based preliminary study

    Article • Surgical Neurology International, January 2014, Medknow

    Prakamya Gupta, Dr Viral N Shah, Dr Anand Srinivasan

  112. Type 1 diabetes and osteoporosis: A review of literature

    Article • Indian Journal of Endocrinology and Metabolism, January 2014, Medknow

    Dr Viral N Shah

  113. Drug utilization pattern and pharmacoeconomic analysis in geriatric medical in-patients of a tertiary care hospital of India

    Article • Journal of Pharmacology and Pharmacotherapeutics, January 2014, Medknow

    Dr Viral N Shah

  114. Pregnancy Outcome in Hyperthyroidism: A Case Control Study

    Article • Gynecologic and Obstetric Investigation, January 2014, Karger Publishers

    Dr Viral N Shah

  115. Non-islet cell tumor-induced hypoglycemia: a report of five cases and brief review of the literature

    Article • November 2013, Bioscientifica

    Dr Viral N Shah

  116. Use of Non-Insulin Therapies for Type 1 Diabetes

    Article • Diabetes Technology & Therapeutics, November 2013, Mary Ann Liebert Inc

    Dr Viral N Shah

  117. The Future of Basal Insulin

    Article • Diabetes Technology & Therapeutics, September 2013, Mary Ann Liebert Inc

    Dr Viral N Shah

  118. Fusarium falciforme Infection of Foot in a Patient with Type 2 Diabetes Mellitus: A Case Report and Review of the Literature

    Article • Mycopathologia, June 2013, Springer Science + Business Media

    Dr Viral N Shah

  119. Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study

    Article • March 2013, Bioscientifica

    Dr Viral N Shah

  120. Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21

    Article • Diabetes, February 2013, American Diabetes Association

    Dr Viral N Shah

  121. Endothelial Nitric Oxide Synthase Gene Polymorphism and the Risk of Diabetic Neuropathy in Asian Indian Patients with Type 2 Diabetes

    Article • Journal of Diabetes & Metabolism, January 2013, OMICS Publishing Group

    Dr Viral N Shah

  122. Angiotensin‐converting enzyme gene variants interact with the renin–angiotensin system pathway to confer risk and protection against type 2 diabetic retinopathy

    Article • Journal of Diabetes Investigation, January 2013, Wiley

    Dr Viral N Shah

  123. Coexistence of gonadal dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome in 46, XX female: A case report and review of literature

    Article • Indian Journal of Endocrinology and Metabolism, January 2013, Medknow

    Dr Viral N Shah

  124. ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes

    Article • Molecular and Cellular Biochemistry, October 2012, Springer Science + Business Media

    Dr Viral N Shah

  125. Chief cell and clear cell parathyroid adenoma do not influence clinical and biochemical expression of the sporadic primary hyperparathyroidism

    Article • Endocrine, October 2012, Springer Science + Business Media

    Dr Viral N Shah

  126. Association of an Osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians

    Article • Clinica Chimica Acta, October 2012, Elsevier

    Dr Viral N Shah

  127. STUDY OF HEMATOLOGICAL PARAMETERS AMONG NEONATES ADMITTED WITH NEONATAL JAUNDICE

    Article • Journal of Evolution of Medical and Dental Sciences, September 2012, Akshantala Enterprises

    Dr Viral N Shah

  128. A bony swelling on the forehead: an uncommon manifestation of a well-known metabolic disease

    Article • BMJ Case Reports, September 2012, BMJ

    Dr Viral N Shah

  129. Microbial Profile and Utility of Soft Tissue, Pus, and Bone Cultures in Diagnosing Diabetic Foot Infections

    Article • Diabetes Technology & Therapeutics, August 2012, Mary Ann Liebert Inc

    Dr Viral N Shah

  130. Authors′ reply

    Article • Indian Journal of Endocrinology and Metabolism, January 2012, Medknow

    Dr Viral N Shah

  131. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism

    Article • Journal of Postgraduate Medicine, January 2012, Medknow

    Dr Viral N Shah

  132. Carotid intima media thickness in patients with sporadic idiopathic hypoparathyroidism: a pilot study

    Article • Endocrine Journal, January 2012, Japan Endocrine Society

    Dr Viral N Shah

  133. Oro-mandibular manifestations of primary hyperparathyroidism

    Article • Indian Journal of Dental Research, January 2012, Medknow

    Dr Viral N Shah, Dr Sachin Rai

  134. Congestive heart failure in acromegaly: A review of 6 cases

    Article • Indian Journal of Endocrinology and Metabolism, January 2012, Medknow

    Dr Viral N Shah

  135. Large but benign adrenal mass: Adrenal oncocytoma

    Article • Indian Journal of Endocrinology and Metabolism, January 2012, Medknow

    Dr Viral N Shah

  136. Pulmonary function tests in patients with primary hyperparathyroidism

    Article • Indian Journal of Endocrinology and Metabolism, January 2012, Medknow

    Dr Viral N Shah

  137. Pituitary dysfunction in survivors of spontaneous subarachnoid hemorrhage of anterior communicating artery and middle cerebral artery aneurysms: A comparative study

    Article • Neurology India, January 2012, Medknow

    Dr Viral N Shah

  138. Clinical Scoring System to Predict Malarial Fever: A Prospective Study

    Article • International Journal of Medicine and Public Health, April 2011, EManuscript Services

    Dr Viral N Shah

  139. High prevalence of cholelithiasis in primary hyperparathyroidism: a retrospective analysis of 120 cases

    Article • Indian Journal of Gastroenterology, March 2011, Springer Science + Business Media

    Dr Viral N Shah

  140. Pituitary metastasis as a presenting manifestation of silent systemic malignancy: A retrospective analysis of four cases

    Article • Indian Journal of Endocrinology and Metabolism, January 2011, Medknow

    Dr Viral N Shah

  141. Vanishing adrenal mass

    Article • BMJ Case Reports, January 2011, BMJ

    Dr Viral N Shah

  142. Fixed drug eruption with ornidazole having cross‐sensitivity to secnidazole but not to other nitro‐imidazole compounds: a case report

    Article • British Journal of Clinical Pharmacology, May 2010, Wiley

    Dr Viral N Shah

  143. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study

    Article • Journal of Diabetes and its Complications, May 2010, Elsevier

    Dr Viral N Shah

  144. Primary hyperparathyroidism with unilateral proptosis

    Article • BMJ Case Reports, January 2010, BMJ

    Dr Viral N Shah

  145. Consensus statement on childhood tuberculosis

    Article • Indian Pediatrics, January 2010, Springer Science + Business Media

    Dr Viral N Shah

  146. Statins

    Article • Journal of Postgraduate Medicine, January 2010, Medknow

    Dr Viral N Shah

  147. Severe myocardial depression in a patient with aluminium phosphide poisoning: A clinical, electrocardiographical and histopathological correlation

    Article • Indian Journal of Critical Care Medicine, January 2009, Medknow

    Dr Viral N Shah

  148. Assessing the knowledge, attitudes and practice of type 2 diabetes among patients of Saurashtra region, Gujarat

    Article • International Journal of Diabetes in Developing Countries, January 2009, Springer Science + Business Media

    Dr Viral N Shah

  149. Gatifloxacin-induced prolongation of QTC interval

    Article • Indian Journal of Pharmacology, January 2006, Medknow

    Dr Viral N Shah

  150. “Diabetic Foot” Complicated by Pneumococcal Cellulitis

    Article • Southern Medical Journal, March 1986, Southern Medical Association

    Dr Viral N Shah